Analyzes phytochemicals and bioactive potential in iris species, highlighting their health implications.
This study examined the phytochemical profiles and bioactive potential of Iris alberti, I. pallasii, and I. sogdiana collected from southeastern Kazakhstan. GC-MS analysis identified fatty acids, sterols, long-chain alcohols, and hydrocarbons in each species. The key phytosterols β-sitosterol, stigmasterol, and campesterol were present in all three. I. alberti showed the highest sterol content of γ-sitosterol (28.49%) and campesterol (6.51%). I. pallasii contained significant amounts of hexacosanol (19.74%) and γ-sitosterol (13.24%), while I. sogdiana was notable for octacosanol (22.87%) and γ-sitosterol (12.18%). Fatty acid composition varied: I. sogdiana was rich in α-linolenic acid (4.77%) and palmitic acid (2.77%), I. pallasii had 3.96% and (3.48%). I. alberti contained dodecanoic acid (3.83%) and branched-chain fatty acids. Tannin content was highest in I. alberti (1.88%), while alkaloid levels were moderate across species (0.63–0.77%). Mineral analysis showed I. pallasii had the highest Ca (586.62 mg/100 g), Mg and K, whereas I. sogdiana had the highest potassium (538.36 mg/100 g). HPLC-DAD analysis revealed distinct phenolic profiles. Water–alcohol extracts from rhizomes of I. alberti had an IC50 of 16.90 ± 6.04 µg/mL in DPPH and were inactive in ABTS. I. pallasii exhibited IC50 values of 28.77 ± 2.93 µg/mL (DPPH) and 10.93 ± 7.29 µg/mL (ABTS), while I. sogdiana showed negligible activity in both assays. Ethyl acetate extracts displayed higher IC50 values, consistent with lower phenolic content.
No takes yet. Share an insight, caveat, or question.
Ramazanova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: